MedPath
HSA Approval

LORAMIDE CAPSULE 2 mg

SIN09217P

LORAMIDE CAPSULE 2 mg

LORAMIDE CAPSULE 2 mg

February 20, 1997

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

A07DA03

loperamide

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

LOPERAMIDE HCl

2 mg

Loperamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LORAMIDE CAPSULE 2 mg - HSA Approval | MedPath